MIRAE ASSET SECURITIES (USA) INC.’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,723
Closed -$7.36M 159
2025
Q4
$7.36M Sell
22,723
-12,277
-35% -$3.89M 0.2% 105
2025
Q3
$9.88M Buy
+35,000
New +$10.2M 0.3% 71
2025
Q2
Sell
-30,000
Closed -$9.35M 214
2025
Q1
$9.35M Sell
30,000
-78,200
-72% -$23.1M 0.26% 101
2024
Q4
$28.2M Buy
+108,200
New +$32.1M 0.85% 31
2024
Q3
Sell
-26,000
Closed -$8.12M 152
2024
Q2
$8.12M Buy
+26,000
New +$7.64M 0.38% 55

Other funds holding AMGN

MIRAE ASSET SECURITIES (USA) INC.'s AMGN Position: Q1 2026 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Amgen (AMGN) in Q1 2026, closing a stake of 22,723 shares — an estimated $7.44M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in AMGN in Q2 2024 and held it in 5 quarters. The position peaked at $9.9M in Q3 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 22,723 Amgen shares in Q1 2026, an estimated $7.44M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Amgen in Q2 2024 and held it in 5 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Amgen position peaked at $9.9M in Q3 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q1 2026, filed 29 Apr 2026.